The publication detail shows the title, authors (with indicators showing other profiled authors), information on the publishing organization, abstract and a link to the article in PubMed. This abstract is what is used to create the fingerprint of the publication. If any grants are referenced by the publication, they will be listed here as well.
Pyruvate dehydrogenase complex: metabolic link to ischemic brain injury and target of oxidative stress.
Department of Anesthesiology, University of Maryland School of Medicine, 684 W. Baltimore Street, Baltimore, MD 21201, USA.
Journal of neuroscience research 2005;79(1-2):240-7.
The mammalian pyruvate dehydrogenase complex (PDHC) is a mitochondrial matrix enzyme complex (greater than 7 million Daltons) that catalyzes the oxidative decarboxylation of pyruvate to form acetyl CoA, nicotinamide adenine dinucleotide (the reduced form, NADH), and CO(2). This reaction constitutes the bridge between anaerobic and aerobic cerebral energy metabolism. PDHC enzyme activity and immunoreactivity are lost in selectively vulnerable neurons after cerebral ischemia and reperfusion. Evidence from experiments carried out in vitro suggests that reperfusion-dependent loss of activity is caused by oxidative protein modifications. Impaired enzyme activity may explain the reduced cerebral glucose and oxygen consumption that occurs after cerebral ischemia. This hypothesis is supported by the hyperoxidation of mitochondrial electron transport chain components and NAD(H) that occurs during reperfusion, indicating that NADH production, rather than utilization, is rate limiting. Additional support comes from the findings that immediate postischemic administration of acetyl-L-carnitine both reduces brain lactate/pyruvate ratios and improves neurologic outcome after cardiac arrest in animals. As acetyl-L-carnitine is converted to acetyl CoA, the product of the PDHC reaction, it follows that impaired production of NADH is due to reduced activity of either PDHC or one or more steps in glycolysis. Impaired cerebral energy metabolism and PDHC activity are associated also with neurodegenerative disorders including Alzheimer's disease and Wernicke-Korsakoff syndrome, suggesting that this enzyme is an important link in the pathophysiology of both acute brain injury and chronic neurodegeneration.
4 Originating Grant
Fiskum, Gary M
11 March 2002 - 30 November 2004
NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES
Zielke, H Ronald
1 May 1997 - 31 January 2009
NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT
MCKENNA, MARY C
1 May 1997 - 31 January 2014
EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT
1 May 1995 - 31 December 2008
NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE
This section shows information related to the publication - computed using the fingerprint of the publication - including related publications, related experts and related grants with fingerprints representing significant amounts of overlap between their fingerprint and this publication. The red dots indicate whether those experts or terms appear within the publication, thereby showing potential and actual connections.
Courtney L Robertson; Susanna Scafidi; Mary C McKenna; Gary FiskumExperimental neurology 2009;218(2):371-80.
Y E Bogaert; K F Sheu; P R Hof; A M Brown; J P Blass; R E Rosenthal; G FiskumExperimental neurology 2000;161(1):115-26.
Gary Fiskum; Robert E Rosenthal; Viktoria Vereczki; Erica Martin; Gloria E Hoffman; Christos Chinopoulos; Alicia KowaltowskiJournal of bioenergetics and biomembranes 2004;36(4):347-52.
Appears in this Publication
Author of this Publication